A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat
Background/Objective: Osilodrostat used with block-and-replace dosing regimen is an off-label alternative to traditional management of Cushing syndrome due to adrenocortical carcinoma (ACC). Case Report: A 70-year-old woman presented with abdominal pain and was found to have a large right adrenal ma...
Saved in:
Main Authors: | Kathleen R. Ruddiman, DO, Catherine E. Price, MD, ECNU, FACE, Alexander K. Bonnecaze, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | AACE Clinical Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060524001147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Finding the Culprit: Cushing Syndrome Secondary to Lung Carcinoid Tumor
by: Richard Vaca, MD, et al.
Published: (2025-01-01) -
A novel approach to intraoperative diagnosis of primary pigmented nodular adrenocortical disease
by: Nethrani Sameera Wijesekara Pathirana, et al.
Published: (2025-02-01) -
Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)
by: Akira Shimatsu, et al.
Published: (2024-12-01) -
Editorial: Advances in diagnostics and management of adrenal tumors
by: Piotr Glinicki, et al.
Published: (2025-01-01) -
Necrosis in Preoperative Cross-Sectional Imaging and Postoperative Histology Is a Diagnostic Marker for Malignancy of Adrenocortical Tumors
by: Agata Dukaczewska, et al.
Published: (2025-01-01)